Expression of C-reactive protein in the human respiratory tract

被引:124
作者
Gould, JM
Weiser, JN
机构
[1] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Pediat Infect Dis, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/IAI.69.3.1747-1754.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C-reactive protein (CRP) is a normal constituent of human sera synthesized by hepatocytes and induced by proinflammatory cytokines. The function of this acute-phase reactant includes activation of complement and enhancement of opsonophagocytosis. CRP binds to phosphorylcholine (ChoP), a constituent of eukaryotic membranes that is also found on the cell surface of major bacterial pathogens of the human respiratory tract, including Streptococcus pneumoniae and Haemophilus influenzae. The presence of CRP on mucosal surfaces and role in innate immunity in the human respiratory tract where ChoP-containing organisms reside have not been previously studied. We have shown using a monoclonal antibody to CRP that CRP is present in inflamed (0.17 to 42 mug/ml) and uninflamed (<0.05 to 0.88 <mu>g/ml) secretions from the human respiratory tract in sufficient quantities for an antimicrobial effect. In addition, the CRP gene was expressed in epithelial cells of the human respiratory tract using in situ hybridization on nasal polyps and reverse transcriptase PCR of pharyngeal cells in culture. The complement-dependent bactericidal activity of normal nasal airway surface fluid and sputum against ChoP expressing H. influenzae was abolished when the secretions were pretreated to remove CRP. In summary, the results indicate that CRP is present in secretions of the human respiratory tract, that human respiratory epithelial cells are capable of CRP expression, and that this protein may contribute to bacterial clearance in the human respiratory tract.
引用
收藏
页码:1747 / 1754
页数:8
相关论文
共 47 条
[1]   Molecular characterization of complement components (C3, C4, and factor B) in human saliva [J].
Andoh, A ;
Fujiyama, Y ;
Kimura, T ;
Uchihara, H ;
Sakumoto, H ;
Okabe, H ;
Bamba, T .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (05) :404-407
[2]   The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface [J].
Bals, R ;
Wang, XR ;
Zasloff, M ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9541-9546
[3]  
BAUMANN H, 1990, MOL BIOL MED, V7, P147
[4]  
BAUMANN H, 1991, J BIOL CHEM, V266, P20424
[5]  
CLAUS DR, 1976, J LAB CLIN MED, V87, P120
[6]   Innate antimicrobial activity of nasal secretions [J].
Cole, AM ;
Dewan, P ;
Ganz, T .
INFECTION AND IMMUNITY, 1999, 67 (07) :3267-3275
[7]   STREPTOCOCCUS-PNEUMONIAE ANCHOR TO ACTIVATED HUMAN-CELLS BY THE RECEPTOR FOR PLATELET-ACTIVATING-FACTOR [J].
CUNDELL, DR ;
GERARD, NP ;
GERARD, C ;
IDANPAANHEIKKILA, I ;
TUOMANEN, EI .
NATURE, 1995, 377 (6548) :435-438
[8]   AN UNUSUAL POLAR LIPID FROM THE CELL-MEMBRANE OF MYCOPLASMA-FERMENTANS [J].
DEUTSCH, J ;
SALMAN, M ;
ROTTEM, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 227 (03) :897-902
[9]   AIRWAY EPITHELIAL-CELLS ARE THE SITE OF EXPRESSION OF A MAMMALIAN ANTIMICROBIAL PEPTIDE GENE [J].
DIAMOND, G ;
JONES, DE ;
BEVINS, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4596-4600
[10]  
DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413